Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference - Medicenna Therapeutics (OTC:MDNAF)

FST Corp. to Present at the 27th Annual H.C. Wainwright Global Investment Conference

BOULDER, CO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- FST Corp. (Nasdaq: KBSX), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced that it will participate in the 27th Annual…

Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference - Medicenna Therapeutics (OTC:MDNAF)

TORONTO and HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:MDNA, OTCQX:MDNAF), a clinical-stage cancer immunotherapy company focused on the development of Superkines, announced today that Dr. Fahar Merchant, President and CEO of Medicenna, will present and participate in one-on-one meetings at the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8-10, 2…

Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

TORONTO and HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage cancer immunotherapy company focused on the development of Superkines, announced today that Dr. Fahar Merchant, President and CEO…

Cancer Immunotherapy Company Medicenna to Showcase Superkine Platform at Global Investment Conference

Medicenna's CEO Dr. Fahar Merchant will present at H.C. Wainwright Global Investment Conference on Sept 9, 2025. Event includes one-on-one meetings and webcast presentation.